EGFR and head and neck squamous cell carcinoma: While some studies do not observe a correlation,37 others describe a correlation between EGFR expression and cetuximab-mediated ADCC.32,38 Clinical reports show discordant results as well39,40 and therefore EGFR expression is currently not a recognised predictive biomarker for cetuximab treatment in HNSCC.